FGF21 and Insulin resistance: Considering that previous reports have demonstrated anti-lipolytic activities of FGF21 and PPARγ37,38, two downstream targets of XBP1s in our study, these findings suggest that the suppression of lipolysis is an additional potential mechanism of XBP1s-induced regulation of insulin resistance.